Dapsone efficacy and adverse events in the management of mucous membrane pemphigoid

European Journal of Dermatology

Volumn 20, Issue 2, 2010, Pages 223-224

  Hegarty, Anne M ^a   Ormond, Martyn ^a   Sweeney, Maureen ^a   Hodgson, Tim ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETAMETHASONE; CYCLOPHOSPHAMIDE; DAPSONE; FLUTICASONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGED; ARTHRALGIA; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DAPSONE SYNDROME; DIZZINESS; DRUG EFFICACY; DRUG INDICATION; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; LETHARGY; LETTER; MALE; MUCOUS MEMBRANE PEMPHIGOID; PANCYTOPENIA; RASH; SYNDROME; TOPICAL TREATMENT;

ADULT; AGED; AGED, 80 AND OVER; DAPSONE; FEMALE; HUMANS; LEPROSTATIC AGENTS; MALE; MIDDLE AGED; PEMPHIGOID, BENIGN MUCOUS MEMBRANE;

EID: 77950398947     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.0847     Document Type: Letter

References (6)

1. Arash A, Shirin L. The management of oral mucous membrane pemphigoid with dapsone and topical corticosteroid. J Oral Pathol Med 2008; 37: 341-344
2. Scully C, Muzio LL. Oral mucosal diseases: Mucous membrane pemphigoid. BJOMFS 2008; 46: 358-366
3. Bagan J, Muzio LL, Scully C. Mucous membrane pemphigoid. Oral Diseases 2005; 11: 197-218.
4. Sacher C, Hunzelmann N. Cicatricial pemphigoid: current and emerging therapeutic approaches. Am J Clin Dermatol 2005; 6: 93-103.
5. Kirtschig G, Murrell D, Wojnarowska F, Khumalo N. Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita. Cochrane database Syst rev 2006; 1: CD004056.
6. Wertheim MS, Males JJ, Cook SD, Tole DM. Dapsone induced haemolytic anaemia in patients treated for ocular cicatricial pemphigoid. Br J Ophthalmol 2006; 90: 516.